Skip to main content
Premium Trial:

Request an Annual Quote

Vibeke Strand and Matthias Schneider

Protagen has appointed Vibeke Strand and Matthias Schneider to its newly formed scientific advisory board. The new board will support the Protagen management team to address the major challenges in diagnosing and treating autoimmune diseases.

Strand currently serves as an adjunct clinical professor in the division of immunology and rheumatology at Stanford Univesity, a position she has held since September 2000. Between March 1993 and May 2000, she was a clinical associate professor.  Schneider currently serves as head of the rheumatology clinic in the Hiller Research Unit at Heinrich-Heine-University in Düesseldorf and Rhein-Ruhr. From 2013 to 2014 he was president of the German Society of Rheumatology. 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.